Fintel reports that on December 19, 2025, HC Wainwright & Co. maintained coverage of Pyxis Oncology (NasdaqGS:PYXS) with a Buy recommendation. Analyst Price Forecast Suggests 474.27% Upside As of ...

Pyxis Tankers Inc. operates as a maritime transportation company with a focus on the tanker and dry-bulk sectors in the United States and internationally. It operates through two segments: Tanker ...

Pyxis Oncology (PYXS) completed sale of its rights to royalties from the commercialization of Enzeshu for a one-time cash payment of $11M. This non-dilutive funding will support the development of ...

Investing.com - Truist Securities has raised its price target on Alnylam Pharmaceuticals (NASDAQ:ALNY) to $535 from $459 while ...

Pyxis Oncology, Inc. engages in the business of developing a multi-modality portfolio of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. The ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...

Abstract: Disaggregating compute from storage is an emerging trend in cloud computing. Effectively utilizing resources in both compute and storage pool is the key to high performance. The state-of-the ...

Singapore-based maritime electrification startup Pyxis has raised S$13 million ($10 million) in the first close of its S$18 million growth funding round, according to an announcement. The financing ...

The overall quant rating is not an average of the factor grades listed. Instead, it gives greater weight to the metrics with the strongest predictive value.

This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed. Chart does not reflect ...